Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
Tóm tắt
Psychological well-being assessment during the COVID-19 pandemic is essential for patients with multiple sclerosis (MS). The goal of this study is to evaluate fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of Iranian patients with MS during the COVID-19 pandemic stage. One hundred and sixty-five patients were enrolled. We asked all cases to fill valid and reliable Persian version of depression, anxiety, and stress scale (DASS-21), perceived social support, and fear of relapse scale questionnaires. One hundred and sixty-five patients were enrolled. Female to male ratio was (F/M) = 4.6. Mean age and mean duration of disease were 35.3±8.6 and 7.1±5 years, respectively. Mean scores of social support, DASS, and FoR questionnaires were 63.1±16.8, 16.4±13.4, and 51.4±17.3, respectively. There was a significant negative correlation between social support and FoR scores and also significant positive correlations between components of DASS and FoR. Linear regression analysis by considering FoR as dependent variable and age, sex, marital status, duration of the disease, and EDSS as dependent variables showed that sex was an independent predictor of FoR score. Psychological well-being as well as fear of relapse should be considered in patients with MS during the COVID-19 pandemic stage.
Tài liệu tham khảo
Ghajarzadeh M et al (2014) Emotional intelligence (EI) of patients with multiple sclerosis (MS). Iran J Public Health 43(11):1550
AZIMI A et al (2019) Prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis. Maedica 14(4):408
Weinshenker BG (1996) Epidemiology of multiple sclerosis. Neurol Clin 14(2):291–308
Halper J (2007) The psychosocial effect of multiple sclerosis: the impact of relapses. J Neurol Sci 256:S34–S38
Ghajarzadeh M, et al. (2016) Validity and reliability of the persian version of the perception de la scle’rose en plaques et de ses pousse’es questionnaire evaluating multiple sclerosis-related quality of life. International journal of preventive medicine 7.
Ozakbas S et al (2004) Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. J Neurol Sci 218(1-2):3–7
Santangelo G et al (2016) Anxiety in multiple sclerosis: psychometric properties of the State-Trait Anxiety Inventory. Acta Neurol Scand 134(6):458–466
Askari F et al (2014) Anxiety in patients with multiple sclerosis: association with disability, depression, disease type and sex. Acta Medica Iranica:889–892
Bonavita S, et al. (2020) Perceived stress and social support in a large population of people with multiple sclerosis recruited online through COVID 19 pandemic. European journal of neurology.
Khatibi A et al (2020) Development and validation of fear of relapse scale for relapsing-remitting multiple sclerosis: understanding stressors in patients. Frontiers in psychiatry 11:226
Costabile T, et al. (2020) COVID-19 pandemic and mental distress in multiple sclerosis: implications for clinical management. Eur J Neurol.
Bonavita S et al (2020) Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic. Neurol Sci 41(5):1007–1009
Asghari A, Saed F, Dibajnia P (2008) Psychometric properties of the Depression Anxiety Stress Scales-21 (DASS-21) in a non-clinical Iranian sample. Int J Psychol 2(2):82–102
Bagherian-Sararoudi R et al (2013) Psychometric properties of the Persian version of the multidimensional scale of perceived social support in Iran. Int J Prev Med 4(11):1277
McDonald WI et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 50(1):121–127
Lorig KR et al (1999) Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care:5–14
Siegert R, Abernethy D (2005) Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 76(4):469–475
Boeschoten RE et al (2017) Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci 372:331–341
Xie Y et al (2020) Factors associated with relapses in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis. Medicine 99:27
Dennison L, Moss-Morris R, Chalder T (2009) A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin Psychol Rev 29(2):141–153
Henry A et al (2019) Anxiety and depression in patients with multiple sclerosis: the mediating effects of perceived social support. Multiple Sclerosis and Related Disorders 27:46–51
Suh Y et al (2012) Physical activity, social support, and depression: possible independent and indirect associations in persons with multiple sclerosis. Psychol Health Med 17(2):196–206
Jaracz K et al (2010) Quality of life and social support in patients with multiple sclerosis. Neurol Neurochir Pol 44(4):358–365
Rezaeimanesh N, Sahraian MA, Moghadasi AN (2020) Evaluation of the Opinion of patients with multiple sclerosis on the outcomes of catching COVID-19 and its effects on the MS symptoms. Basic and clinical neuroscience 11(2):201
Zanghì A et al (2020) Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: a monocentric experience. Mult Scler Relat Disord 46:102561
Stojanov A et al (2020) Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak. Mult Scler Relat Disord 45:102407